Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Trials, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 6,049)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 193 tweets from 149 users, with an upper bound of 318,272 followers.

@kevinnbass Bullshit. The NIH says #IvermectinWorks, not only for the #WuFlu but for cancer. Research is your friend. They didn't get it wrong, they LIED about it. They're still covering up their lies. https://t.co/Wrur7Wxr50 https://t.co/eTGB5PA9qW)

@PhyloSeFizer @mtaibbi Yes, yes and yes! To find the truth you must look to all sides and inside, then follow the Data or the money! 1. ivermectin against Covid? https://t.co/eDJpke4TlJ✅ https://t.co/uEXxTQ9J1V https://t.co/Z27eROymT1 https://t.co/n8tY

@BillyCarruther3 @austinrobu @theserfstv It isn't every study. Randomized controlled trials, the gold standard for medical evidence, have repeatedly found no effect on COVID-19 outcomes with use of ivermectin https://t.co/gLPIU4Ccka https://t.co/mujVw3J

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 189 additional tweets.